will insurance cover glp-1 for high cholesterol Employers Take a Variety of Approaches to Coverage Costly GLP-1 Drugs are Rarely
Description
The preference for SGLT2i is due to more robust evidence regarding renal outcomes
If so, how
First, retatrutide requires larger injection volumes at maintenance doses
Similarly, TZDs are as effective as GLP-1RAs in HbA 1C reduction, have fewer GI effects and may have a lower hypoglycaemia risk, but can cause weight gain
Tracked data from an app like Shotsy, exported as a PDF, can support this process
This review aims to distinguish between the two treatment classes
